They found that Z-LIG metabolized to EM-Lig could reduce HMGCS1 enzyme activity by attacking Cys129 of HMGCS1 to block its acetylation, thereby reducing cholesterol biosynthesis and ameliorating dyslipidemia [21]. This evidence concerns the gene HMGCS1 and metabolic syndrome.